miR‑449a and CDK6 in gastric carcinoma

Li,Li‑Ping; Wu,Wei‑Jing; Sun,Da‑Yong; Xie,Zi‑Ying; Ma,Yan‑Chun; Zhao,Ya‑Gang

doi:10.3892/ol.2014.2370

October 2014 Volume 8 Issue 4

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

October 2014 Volume 8 Issue 4

Full Size Image

Article

miR‑449a and CDK6 in gastric carcinoma

Authors:
- Li‑Ping Li
- Wei‑Jing Wu
- Da‑Yong Sun
- Zi‑Ying Xie
- Yan‑Chun Ma
- Ya‑Gang Zhao
View Affiliations / Copyright

Affiliations: Department of Gastroenterology, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou, Guangdong 510010, P.R. China, Department of Respiratory Medicine, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian 362000, P.R. China
Pages: 1533-1538
|
Published online on: July 22, 2014

https://doi.org/10.3892/ol.2014.2370
Expand metrics +

Abstract

The present study aimed to identify the association between microRNA (miR/miRNA)‑449a, the cyclin‑dependent kinase (CDK)6 protein and gastric carcinoma, and discuss the effect of miR‑449a on the expression of the CDK6 protein. Quantitative (q)PCR and western blot analysis were used to analyze the expression of the miR‑449a and the CDK6 protein in gastric carcinoma and tumor‑adjacent normal tissues. The real‑time cell analyzer and the DAPI staining test were used to monitor the different miR‑449a levels regulating the proliferation and apoptosis of the MGC‑803 cell line. Immunofluorescence and western blot analyses were used to detect the expression level of the CDK6 protein in the cells of the miR‑449a upregulation and downregulation groups, and a control group. A scratch test was used to study the effects of miR‑449a expression on migration and invasion. It was found that the expression of miR‑449a was downregulated and the expression of CDK6 protein was upregulated in gastric carcinoma tissue. The level of MGC‑803 cell proliferation was decreased and the apoptosis level was increased by the upregulation of miR‑449a expression, and the opposite effect was shown by the downregulation of expression. The expression of the CDK6 protein in the MGC‑803 cells was downregulated by upregulating the expression of miR‑449a. The distance of the scratch was shortened markedly after 12 h by downregulating the expression of miR‑449a in the MGC‑803 cells. The present study identified that a lower expression level of miR‑449 and a higher expression level of CDK6 may contribute to the occurrence and development of gastric cancer. Furthermore, it was shown that miR‑449a is able to regulate the expression of the CDK6 protein.

View Figures

View References

1	Smith MG, Hold GL, Tahara E, et al: Cellular and molecular aspects of gastric cancer. World J Gastroenterol. 12:2979–2990. 2006.
2	Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011.
3	Stenvang J, Petri A, Lindow M, et al: Inhibition of microRNA function by antimiR oligonucleotides. Silence. 3:12012.
4	Wu WK, Lee CW, Cho CH, et al: MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene. 29:5761–5771. 2010.
5	Lizé M, Klimke A and Dobbelstein M: MicroRNA-449 in cell fate determination. Cell Cycle. 10:2874–2882. 2011.
6	Teng Z, Kuang X, Wang J and Zhang X: Real-time cell analysis - a new method for dynamic, quantitative measurement of infectious viruses and antiserum neutralizing activity. J Virol Methods. 193:364–370. 2013.
7	Bou Kheir T, Futoma-Kazmierczak E, Jacobsen A, et al: miR-449 inhibits cell proliferation and is down-regulated in gastric cancer. Mol Cancer. 10:292011.
8	Chan SH, Wu CW, Li AF, et al: miR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res. 28:907–911. 2008.
9	Tsujiura M, Ichikawa D, Komatsu S, et al: Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer. 102:1174–1179. 2010.
10	Duman-Scheel M, Weng L, Xin S and Du W: Hedgehog regulates cell growth and proliferation by inducing Cyclin D and Cyclin E. Nature. 417:299–304. 2002.
11	Kozar K and Sicinski P: Cell cycle progression without cyclin D-CDK4 and cyclin D-CDK6 complexes. Cell Cycle. 4:388–391. 2005.
12	Laman H, Funes JM, Ye H, et al: Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6. EMBO J. 24:3104–3116. 2005.
13	Cam EJ, Liu BD, Bjeldanes LF and Firestone GL: Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Sp1 transcription factor interactions with a composite element in the CDK6 gene promoter. J Biol Chem. 276:22332–22340. 2001.
14	Yang XJ, Feng M, Jiang X, et al: miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A. Genes Dev. 23:2388–2393. 2009.
15	Feng M and Yu Q: miR-449 regulates CDK-Rb-E2F1 through an auto-regulatory feedback circuit. Cell Cycle. 9:213–214. 2010.
16	Lizé M, Herr C, Klimke A, et al: MicroRNA-449a levels increase by several orders of magnitude during mucociliary differentiation of airway epithelia. Cell Cycle. 9:4579–4583. 2010.
17	Bhatia S, Kaul D and Varma N: Functional genomics of tumor suppressor miR-196b in T-cell acute lymphoblastic leukemia. Mol Cell Biochem. 346:103–116. 2011.
18	Guan Y, Mizoguchi M, Yoshimoto K, et al: MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance. Clin Cancer Res. 16:4289–4297. 2010.
19	Katsios C, Baltogiannis G and Roukos DH: Progress, challenges and new genome-based concepts in the multidisciplinary treatment of gastric cancer. Expert Rev Anticancer Ther. 11:503–506. 2011.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

miR‑449a and CDK6 in gastric carcinoma

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Related Articles